The company
Axsome Therapeutics, Inc.
AXSM · Nasdaq
AXSM stood above a rising 150-day average in 46 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 24.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 4
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $235.2M
- Officials’ trades on record
- 1
- Institutions holding
- 481 (+92)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 46 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
1 disclosed lines: House 1, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Chris Jacobs House: U.S. House ClerkNY27 | bought | $15k–$50k | 16 Jun 2022filed 28 Jul 2022 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Mark L. JacobsonChief Operating Officer | sold | 10,000at $208.65 | 3 Sep 2026filed 3 Sep 2026 |
| Herriot TabuteauChief Executive Officer | sold | 4,660at $213.95 | 6 Aug 2026filed 7 Aug 2026 |
| Herriot TabuteauChief Executive Officer | sold | 45,004at $212.01 | 5 Aug 2026filed 7 Aug 2026 |
| Herriot TabuteauChief Executive Officer | sold | 49,666at $240.25 | 1 Jul 2026filed 1 Jul 2026 |
| Roger JeffsDirector | sold | 286at $249.12 | 11 Jun 2026filed 11 Jun 2026 |
| Mark ColemanDirector | sold | 643at $249.00 | 10 Jun 2026filed 10 Jun 2026 |
| Susan MahonyDirector | sold | 300at $246.18 | 10 Jun 2026filed 10 Jun 2026 |
| Roger JeffsDirector | sold | 286at $246.18 | 10 Jun 2026filed 11 Jun 2026 |
| Nick PizzieChief Financial Officer | sold | 33,000at $240.09 | 9 Jun 2026filed 9 Jun 2026 |
| Herriot TabuteauChief Executive Officer | sold | 49,670at $241.01 | 9 Jun 2026filed 9 Jun 2026 |
| Susan MahonyDirector | sold | 300at $237.21 | 9 Jun 2026filed 10 Jun 2026 |
| Mark ColemanDirector | sold | 5,537at $223.39 | 2 Jun 2026filed 2 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 3,103,708$759.7M | -809,136−20.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 1,983,514$485.5M | -74,656−3.6% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,965,086$481.0M | +27,334+1.4% |
| Invesco Ltd.added · filed 14 Aug 2026 | 1,671,684$409.2M | +374,006+28.8% |
| FMR LLCreduced · filed 13 Aug 2026 | 1,539,163$376.7M | -27,832−1.8% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 967,172$236.8M | -195,809−16.8% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 804,082$196.8M | +327,381+68.7% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 785,661$192.3M | -201,148−20.4% |
| Deep Track Capital, LPreduced · filed 14 Aug 2026 | 700,000$171.3M | -400,000−36.4% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 669,478$163.9M | +346,700+107.4% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.